Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178682 | SCV000230809 | uncertain significance | not provided | 2015-05-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001176082 | SCV000738894 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-09-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001079202 | SCV001018078 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-10-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000130 | SCV001156575 | benign | not specified | 2019-05-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001176082 | SCV001339920 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-03-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996575 | SCV004814616 | benign | Marfan syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing |